Target versus below-target dose ACE inhibitors in US veterans with HFpEF: differential outcomes by CKD status
Year: 2026
Type: article
Study design: Observational Study
DOI: 10.1093/ejhf/xuag237
Authors: Frederick Lu, Amiya A Ahmed, Sijian Zhang, Venkatesh K Raman, Samir S Patel, Jose D Vargas, Gregg C Fonarow, Paul A Heidenreich, John G F Cleland, Stefan D Anker, Michael Böhm, Marco Metra, Michael R Zile, Deepak L Bhatt, Tariq Ahmad, Phillip H Lam, Hans J Moore, Charles Faselis, Charity J Morgan, Helen M Sheriff, Qing Zeng-Treitler, Wen-Chih Wu, Ali Ahmed
Institutions: Brown University, Veterans Health Administration, Washington DC VA Medical Center, Georgetown University, George Washington University, Yale University, University of California, Los Angeles, VA Palo Alto Health Care System, Stanford Medicine, Stanford University, University of Glasgow, Wroclaw Medical University, German Centre for Cardiovascular Research, Charité – Universitätsmedizin Berlin, Saarland University, IRCCS Ospedale San Raffaele, Medical University of South Carolina, Icahn School of Medicine at Mount Sinai, MedStar Heart & Vascular Institute, Uniformed Services University of the Health Sciences, University of Alabama at Birmingham, Providence VA Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7171811882